BCTX BRIACELL THERAPEUTICS CORP Management Changes 8-K Filing 2025 - Annual Meeting Results BriaCell Therapeutics Corp. held its Annual General Meeting on February 5, 2025, where shareholders ratified the appointment of MNP LLP as auditors and elected six directors for the Board, with a total of 13,335,031 shares represented at the meeting.Get access to all SEC 8-K filings of the BRIACELL THERAPEUTICS CORP